Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

649 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 102
Recruiting: 49
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (104)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07758218	Allogeneic iNKT Cell Therapy (agenT-797) After SCT	not yet recruiting	Phase 1	22	University of Wisconsin, MadisonOTHER	1	Aug 11, 2026	clinicaltrials
NCT07254793	Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT	not yet recruiting	Phase 1	94	University of ArizonaOTHER	1	Jul 13, 2026	clinicaltrials